EE02970B1 - Veeslahustuvate ainete konditsioneerimise protsess - Google Patents

Veeslahustuvate ainete konditsioneerimise protsess

Info

Publication number
EE02970B1
EE02970B1 EE9400417A EE9400417A EE02970B1 EE 02970 B1 EE02970 B1 EE 02970B1 EE 9400417 A EE9400417 A EE 9400417A EE 9400417 A EE9400417 A EE 9400417A EE 02970 B1 EE02970 B1 EE 02970B1
Authority
EE
Estonia
Prior art keywords
soluble substances
conditioning water
vacuum
water
micronised
Prior art date
Application number
EE9400417A
Other languages
English (en)
Estonian (et)
Inventor
Ann-Christin Trofast Eva
Trofast Jan
Bystr�m Katarina
Jakupovic Edib
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE02970(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE02970B1 publication Critical patent/EE02970B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Treating Waste Gases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cephalosporin Compounds (AREA)
EE9400417A 1991-04-11 1994-11-17 Veeslahustuvate ainete konditsioneerimise protsess EE02970B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
EE02970B1 true EE02970B1 (et) 1997-04-15

Family

ID=20382434

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400417A EE02970B1 (et) 1991-04-11 1994-11-17 Veeslahustuvate ainete konditsioneerimise protsess

Country Status (28)

Country Link
US (1) US5562923A (ru)
EP (3) EP0580648B1 (ru)
JP (2) JP3400999B2 (ru)
KR (1) KR100216384B1 (ru)
AT (2) ATE137671T1 (ru)
AU (1) AU662519B2 (ru)
BG (1) BG61474B1 (ru)
CA (1) CA2106975C (ru)
CZ (1) CZ286936B6 (ru)
DE (2) DE69232207T2 (ru)
DK (2) DK0580648T3 (ru)
EE (1) EE02970B1 (ru)
ES (2) ES2086733T3 (ru)
FI (1) FI105388B (ru)
GR (1) GR3020602T3 (ru)
HK (1) HK52497A (ru)
HU (1) HU211116B (ru)
IE (1) IE921144A1 (ru)
IS (1) IS3834A (ru)
NO (1) NO311867B1 (ru)
PL (1) PL168232B1 (ru)
PT (1) PT680752E (ru)
RO (1) RO115779B1 (ru)
RU (1) RU2112507C1 (ru)
SE (1) SE9101090D0 (ru)
SG (1) SG43180A1 (ru)
SK (1) SK280310B6 (ru)
WO (1) WO1992018110A1 (ru)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
CN1090935C (zh) * 1995-02-28 2002-09-18 阿温蒂斯药物公司 哌啶子基烷醇化合物的药物组合物
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
ID24472A (id) * 1997-03-20 2000-07-20 Schering Corp Pembuatan aglomerat bubuk
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
SK285068B6 (sk) * 1997-09-29 2006-05-04 Nektar Therapeutics Práškový prostriedok, mikrosféry, spôsob tvorby časticového prostriedku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním a spôsob tvorby prášku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
CA2519779A1 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
JP4956185B2 (ja) 2003-06-13 2012-06-20 スケンディ ファイナンス リミテッド 避妊及びホルモン補充療法用の調合製剤
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005037539A1 (en) * 2003-10-17 2005-04-28 E.I. Dupont De Nemours And Company Adhesion of foil to thermoplastic polymers
EP1711166A1 (en) 2004-02-03 2006-10-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
KR20100099281A (ko) * 2007-12-13 2010-09-10 노파르티스 아게 유기 화합물
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
WO2013001294A1 (en) 2011-06-29 2013-01-03 Astrazeneca Ab Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders
KR102391332B1 (ko) * 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
ES2168322T3 (es) 2002-06-16
US5562923A (en) 1996-10-08
CZ286936B6 (cs) 2000-08-16
KR100216384B1 (ko) 1999-08-16
DE69232207D1 (de) 2001-12-20
RO115779B1 (ro) 2000-06-30
BG61474B1 (en) 1997-09-30
AU662519B2 (en) 1995-09-07
ATE137671T1 (de) 1996-05-15
PL168232B1 (pl) 1996-01-31
EP0508969A1 (en) 1992-10-14
SK280310B6 (sk) 1999-11-08
JP2003155228A (ja) 2003-05-27
BG98147A (bg) 1994-12-02
NO311867B1 (no) 2002-02-11
SG43180A1 (en) 1997-10-17
AU1534792A (en) 1992-11-17
ATE208613T1 (de) 2001-11-15
NO933575D0 (no) 1993-10-06
EP0680752B1 (en) 2001-11-14
FI934429A0 (fi) 1993-10-08
RU2112507C1 (ru) 1998-06-10
EP0580648B1 (en) 1996-05-08
IS3834A (is) 1992-10-12
EP0680752A2 (en) 1995-11-08
ES2086733T3 (es) 1996-07-01
HU211116B (en) 1995-10-30
HU9302870D0 (en) 1993-12-28
FI934429A (fi) 1993-10-08
GR3020602T3 (en) 1996-10-31
HUT65095A (en) 1994-04-28
SE9101090D0 (sv) 1991-04-11
WO1992018110A1 (en) 1992-10-29
DE69210601T2 (de) 1996-10-02
DK0580648T3 (da) 1996-09-16
PT680752E (pt) 2002-05-31
IE921144A1 (en) 1992-10-21
CA2106975A1 (en) 1992-10-12
DK0680752T3 (da) 2002-02-25
EP0580648A1 (en) 1994-02-02
EP0680752A3 (ru) 1995-11-22
CA2106975C (en) 2002-03-19
DE69232207T2 (de) 2002-08-01
DE69210601D1 (de) 1996-06-13
SK108893A3 (en) 1994-03-09
JP3400999B2 (ja) 2003-04-28
NO933575L (no) 1993-10-06
FI105388B (fi) 2000-08-15
HK52497A (en) 1997-05-02
JPH06506454A (ja) 1994-07-21
CZ211693A3 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
SE9101090D0 (sv) Process for conditioning of water-soluble substances
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
DE69106828D1 (de) Antimykotische Zusammensetzung in Trocken Aerosol Form.
JPS56830A (en) Surface treatment of acrylic resin molded product
DE3164422D1 (en) Immunosuppressive compound, process for isolating it and its therapeutical use
JPS51151693A (en) Coated bead-like activated carbon for blood purification
EP0341696A3 (en) A process for drying water-wet polycarbonate membranes
IT7885588A0 (it) Mezzo propellente adinfiammabilita' ridotta per aerosol, procedimento per la suaproduzione e dispositivo per la realizzazione del procedimento.
JPS51142488A (en) Novel photocromic material
JPS5241192A (en) Process for concentrating or storing ozone by adsorption
JPS5259212A (en) Vehicle use air cleaner
JPS53112288A (en) Controlling method for substance permeability of semipermeable membrane
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS5281078A (en) Permeable membrane module
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS5232042A (en) Method to prevent polyethylene cross-linked with organosilane from deg radation
JPS526738A (en) Crosslinkable coating materials
JPS5250040A (en) Emergent cutoff for gas leakage
JPS6440922A (en) Dew condensation preventing method for optical unit
JPS5220410A (en) Noise preventiue method of compressor
JPS51118216A (en) Container loading and unloading apparatus for truck
JPS51124989A (en) Sampling apparatus for liquid
JPS51120504A (en) Pneumatic tire
JPS5348989A (en) Artificial kidney

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231